Novavax CEO John C. Jacobs called the decision "a significant milestone" and emphasized the company's commitment to vulnerable populations. The CDC has noted that these groups will most likely seek ...
Novavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for Novavax's COVID-19 vaccine and take a ...
Shares for Novavax swelled by more than 130% Friday morning, after the biotech firm announced a $1.4 billion deal with Sanofi to commercialize its Covid vaccine and develop a new combination shot for ...
Hosted on MSN
Novavax Stock Rips Nearly 20% Pre-Market After FDA Approves Its COVID-19 Vaccine Nuvaxovid
Pharmaceutical giant Novavax on Monday announced that the U.S. Food and Drug Administration (FDA) approved its COVID-19 vaccine, Nuvaxovid. Novavax’s shares traded nearly 20% in pre-market trading at ...
Novavax's stock almost doubled on Friday after it announced the licensing agreement with Sanofi. Novavax on Friday said the deal allows the company to remove its "going concern" warning, which it ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Gaithersburg biotech has ...
Don’t call it a comeback: Novavax just (briefly) became a meme stock. The Maryland-based biotech joined the likes of Ango American, Vodafone and the notorious GameStop in a resurgence of the meme ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The updated shot is authorized ...
Shares of Novavax closed nearly 50% higher on Monday as Wall Street cheered the company's new multibillion-dollar deal with French drugmaker Sanofi that sparked a dramatic turnaround for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback